Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today new data from the positive Phase III FENhance 1 and 2 studies, which met their primary endpoint. The studies showed ...
Researchers in Barcelona have demonstrated that chemical patterning can direct cell orientation within tissues which enables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results